Immutep in pursuing this self protective agenda is a hint of research
confidence coming from our chief scientist and his research labs.....
Immutep is basically securing it's future if Frederic and his team
can get "Efti" over the line.....The fundamentals of a sound business
base are there but let's not get carried away yet, the business is
not ready to produce and production is not assured......
Ann: Immutep granted European patent for eftilagimod alpha, page-3
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.005(1.82%) |
Mkt cap ! $407.2M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.5¢ | 27.0¢ | $352.6K | 1.266M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 156231 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 2491 | 1 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |